The Innovation Studio at Children’s Hospital Los Angeles (CHLA), today announced10 semi-finalists from the first ever Gamifying Pediatrics Hackathon, which took place April 12-14, 2019 at BCG Digital Ventures (BCGDV) in Manhattan Beach (CA), the global corporate venture and incubation arm of the Boston Consulting Group. This hackathon brought together 185 enthusiastic participants, including physicians and nurses on the front lines of pediatric medicine, engineers, developers, and experts in
Read More
Impact of Diabetes Management for Patients, Payers, and Providers| News, Policy, Analysis, Insights - HIT Consultant
Livongo Adds HIPAA-Compliant Amazon Alexa Healthcare Skill for Diabetes
Livongo, the leading Applied Health Signals company, today announced the Livongo for Diabetes program will now leverage Amazon Alexa's voice service to offer its Members the ability to ask any of their Alexa-enabled devices to provide their blood glucose readings and health tips via the new Livongo skill. The integration marks Livongo as the first consumer digital health company to collaborate with Amazon Alexa on a new HIPAA-compliant healthcare skill, which builds on Livongo's efforts to make
Read More
Biolinq Lands $4.75M to Expand Biosensor Patch for Continuous Glucose Monitoring
Biolinq, a San Diego, CA-based digital health company developing a minimally-invasive electrochemical biosensor patch for continuous glucose monitoring (CGM) has raised $4.75 million in Series A funding led by the JDRF T1D Fund, Aphelion Capital and LifeSci Venture Partners. Existing investors in the round include M Ventures and Hikma Ventures, the corporate venture capital arm of Hikma Pharmaceuticals. The latest round brings Biolinq’s total Series A funding to $15 million.Inception of
Read More
DarioHealth Integrates Blood Glucose Data with Glytec’s Outpatient Insulin Management Solution
DarioHealth Corp., a blood glucose monitoring system has announced a joint marketing agreement with Glytec, a provider of insulin titration solutions. As part of the partnership, Dario Blood Glucose Monitoring System is now available to hospitals and health systems using Glytec’s virtual insulin titration service for outpatients with diabetes.Integration Details & BenefitsBlood glucose data from the Dario Blood Glucose Monitoring System automatically sent to the Cloud in real-time, will be
Read More
Amazon Choice Integrates with One Drop for Diabetes and Hypertension Management
One Drop, a provider of digital therapeutics solutions, today announced an integration partnership with Amazon’s exclusive health brand, Choice. The integration with One Drop’s app will provide Amazon’s Choice customers living with diabetes and hypertension with affordable, accessible, and comprehensive digital health management services.One Drop/Amazon Choice Integration BenefitsLaunched in late 2018, Amazon Choice was developed by Arcadia Group to offer an array of affordable medical devices
Read More
NHS England Publishes New Guidelines on Flash Glucose Monitors for Type 1 Diabetes Patients
NHS England recently published clinical guidance for flash glucose monitors that outlines funding arrangements for patients with type 1 diabetes and the qualifying criteria to support local health groups. According to NHS England, an estimated 260,000 in England suffer from type 1 diabetes.Starting in April, the NHS will provide the technology for one in five of those with type 1 diabetes in England. Those who qualify include:- People with type 1 diabetes who need intensive monitoring (more than
Read More
Fitbit Partners with Solera Health to Address Type 2 Diabetes
Fitbit, today announced its expanded partnership with Solera Health, an integrated benefit network to reduce the risk of type 2 diabetes by encouraging positive behavior changes, such as increased physical activity and weight loss.Type 2 diabetes affects more than 30 million American adults and costs the U.S. approximately $327 billion annually in direct medical expenses and lost productivity. Yet, the onset of disease can be delayed – or even prevented – among the 84 million U.S. adults at high
Read More
New Saliva Glucose Biosensor Could Eliminate Finger Pricks for Diabetes
New non-invasive, saliva-based glucose test measures glucose in saliva rather than blood could eliminate finger pricks for diabetes management.The iQ Group Global, a Sydney, Australia-based consortium of life science and financial services companies has unveiled the Saliva Glucose Biosensor, a non-invasive, saliva-based glucose test for diabetes management that measures glucose in saliva rather than blood. The saliva-based glucose test could eliminate painful finger pricks for diabetes
Read More
Abbott Integrates Insulin Dose Data with Novo Nordisk Insulin Pens
Abbott and Novo Nordisk today announced a non-exclusive partnership that will integrate insulin dose data from Novo Nordisk pre-filled and durable connected pens directly into the digital health tools compatible with the FreeStyle Libre system (FreeStyle LibreLinkii mobile app and LibreViewiii cloud-based system). The integration between Abbott and Novo Nordisk’s products will enable healthcare professionals, caregivers and people with diabetes to view glucose and insulin data together to help
Read More
FDA Authorizes Interoperable Tandem Insulin Pump for Personalized Diabetes Management
The U.S. Food and Drug Administration (FDA) has permitted marketing of the Tandem Diabetes Care t:Slim X2 insulin pump with interoperable technology (interoperable t:Slim X2) for delivering insulin under the skin for children and adults with diabetes. This new type of insulin pump, Referred to as an alternate controller enabled (ACE) infusion pump, or ACE insulin pump, is the first interoperable insulin pump, meaning it can be used with different components that make up diabetes therapy systems,
Read More
